Table 1. Basic Demographic and Clinical Characteristics of New Presenters, by Enrollment Year.
| No. (%) | ||||||
|---|---|---|---|---|---|---|
|
|
||||||
| 2003-04 | 2005-06 | 2007-08 | 2009-10 | 2011-12 | 2003-2012 | |
| Variable | N = 2920 | N = 2808 | N = 3274 | N = 3097 | N = 3173 | N=15,272 |
| Age(years) | 38.2 (9.7) | 38.3 (10.2) | 38.6 (11.0) | 37.7 (11.3) | 37.6 (11.5) | 38.1 (10.8) |
| Age Category† | ||||||
| ≤30 | 654 (22.4) | 695 (24.8) | 872 (26.6) | 959 (31.0) | 1056 (33.3) | 4236 (27.7) |
| 31-40 | 1114 (38.2) | 923 (32.9) | 948 (29.0) | 826 (26.7) | 820 (25.8) | 4631 (30.3) |
| 41-50 | 828 (28.4) | 877 (31.2) | 988 (30.2) | 887 (28.6) | 831 (26.2) | 4411 (28.9) |
| >50 | 324 (11.1) | 313 (11.1) | 466 (14.2) | 425 (13.7) | 466 (14.7) | 1994 (13.1) |
| Race/Ethnicity† | ||||||
| Black | 1327 (45.4) | 1347 (48.0) | 1623 (49.6) | 1604 (51.8) | 1496 (47.1) | 7397 (48.4) |
| White | 862 (29.5) | 774 (27.6) | 832 (25.4) | 741 (23.9) | 787 (24.8) | 3996 (26.2) |
| Hispanic | 660 (22.6) | 564 (20.1) | 696 (21.3) | 625 (20.2) | 765 (24.1) | 3310 (21.7) |
| Other | 71 (2.4) | 123 (4.4) | 123 (3.8) | 127 (4.1) | 125 (3.9) | 569 (3.7) |
| Gender† | ||||||
| Male | 2195 (75.2) | 2119 (75.5) | 2470 (75.4) | 2388 (77.1) | 2579 (81.3) | 11751(76.9) |
| Female | 725(24.8) | 689(24.5) | 804(24.6) | 709(22.9) | 975 (30.7) | 3521(23.1) |
| HIV Risk† | ||||||
| HET | 1078 (36.9) | 1093 (38.9) | 1236 (37.8) | 1165 (37.6) | 975 (30.7) | 5547 (36.3) |
| MSM | 1173 (40.2) | 1208 (43.0) | 1407 (43.0) | 1468 (47.4) | 1727 (54.4) | 6983 (45.7) |
| IDU | 440 (15.1) | 344 (12.3) | 409 (12.5) | 267 (8.6) | 199 (6.3) | 1659 (10.9) |
| Other | 229 (7.8) | 163 (5.8) | 222 (6.8) | 197 (6.4) | 272 (8.6) | 1083 (7.1) |
| CD4 Category (cells/mm3) † | ||||||
| ≥500 | 570 (19.5) | 568 (20.2) | 674 (20.6) | 696 (22.5) | 870 (27.4) | 3378 (22.1) |
| 350-499 | 561 (19.2) | 540 (19.2) | 643 (19.6) | 631 (20.4) | 633 (20.0) | 3008 (19.7) |
| 200-349 | 627 (21.5) | 607 (21.6) | 759 (23.2) | 715 (23.1) | 716 (22.6) | 3424 (22.4) |
| <200 | 1162 (39.8) | 1093 (38.9) | 1198 (36.6) | 1055 (34.1) | 954 (30.1) | 5462 (35.8) |
| Log10 HIV RNA (copies/ml), median(IQR) † | ||||||
| 4.6 | 4.7 | 4.5 | 4.4 | 4.5 | 4.5 | |
| (4.0 - 5.2) | (4.0 - 5.1) | (3.8 - 5.0) | (3.8 - 5.0) | (3.7 - 5.0) | (3.8-5.1) | |
| Survival Time (days), 50th Percentile (25th-75th) | ||||||
| AI | 109 | 131 | 75 | 40 | 15 | 54 |
| (9-1041) | (10-1001) | (6-672) | (0-389) | (0-183) | (1-626) | |
| VS | 763 | 702 | 508 | 303 | 235 | 458 |
| (155-1675) | (165-1583) | (131-1165) | (100-965) | (95-770) | (121-1296) | |
| Cumulative Incidence (%) | ||||||
| AI | 69.7 | 69.9 | 74.5 | 80.1 | 84.0 | |
| VS | 51.0 | 52.2 | 57.9 | 63.7 | 66.6 | |
*
AI – ART initiation, VS – HIV virologic suppression
†
Association of variable with biennial period is significant, p<0.001.